Volume | 4,987,927 |
|
|||||
News | - | ||||||
Day High | 1.14 | Low High |
|||||
Day Low | 1.06 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Bionano Genomics Inc | BNGO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.13 | 1.06 | 1.14 | 1.08 | 1.13 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
11,168 | 4,987,927 | $ 1.11 | $ 5,515,695 | - | 1.06 - 4.35 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:59:55 | 10 | $ 1.08 | USD |
Bionano Genomics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 330.74M | 306.24M | 306.06M | $ 27.80M | $ - | -0.46 | -3.10 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | - | - | 2.00% |
Bionano Genomics News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BNGO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.18 | 1.28 | 1.06 | 1.20 | 6,568,963 | -0.10 | -8.47% |
1 Month | 1.49 | 1.49 | 1.06 | 1.29 | 6,568,587 | -0.41 | -27.52% |
3 Months | 1.50 | 2.02 | 1.06 | 1.56 | 6,586,177 | -0.42 | -28.0% |
6 Months | 2.14 | 3.01 | 1.06 | 1.90 | 6,993,497 | -1.06 | -49.53% |
1 Year | 2.37 | 4.35 | 1.06 | 2.06 | 7,164,561 | -1.29 | -54.43% |
3 Years | 0.425 | 15.685 | 0.25 | 4.63 | 17,079,077 | 0.655 | 154.12% |
5 Years | 10.00 | 15.685 | 0.25 | 4.51 | 11,934,537 | -8.92 | -89.2% |
Bionano Genomics Description
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. |